Cannabis & Cannabinoid Research – All Issues – Sage Journals
The Cannabis Cannabinoid Research Journal by Sage offers peer-reviewed cannabis research essential for clinicians. This journal covers clinical trials, pharmacology, and therapeutic applications. Access to this research supports evidence-based cannabis…
Texas Ban on Smokeable Hemp Begins Tuesday
Texas hemp ban 2026 begins Tuesday, closing a loophole that allowed high-THC smokeable hemp sales. Clinicians must understand this shift when advising patients on cannabis use. This ban affects product availability and patient safety in Texas.
Cannabis Use Exacerbates Paranoia in Survivors of Chaotic Childhoods, New Study Suggests
A new study reveals cannabis use paranoia trauma interactions in survivors of chaotic childhoods. This research highlights how cannabis may amplify paranoid symptoms in trauma survivors. Understanding cannabis use paranoia trauma risks is essential for…
N.S. Sees Surge in Ancestral Record Requests Following New Bill
This item covers cannabis news clinical practice developments relevant to clinicians and researchers. Emerging findings and policy changes are worth monitoring closely. Clinicians should review the source material for full context.
Gerontological Advanced Practice Nurses Association
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic GerontologicalAdvancedPracticeNurses Why…
Exploring Nonmonotonic Associations Between Cannabis Use and Alcohol
This article examines nonmonotonic cannabis alcohol use frequency associations and their implications for clinical practice. Understanding these patterns helps clinicians monitor patient outcomes more effectively. Nonmonotonic cannabis alcohol use…
Senate Bill Broadens Cannabis Access in Georgia: Clinical Insights
Georgia cannabis access expansion is clinically significant for evidence-based medicine. This legislation broadens product availability but raises concerns about dosing and safety. Clinicians should monitor these changes closely for patient guidance.
Many Industry Standards Stem from Bom Group’s Innovations
Bom Group's cannabis manufacturing quality control innovations have significantly influenced industry standards. These standards improve product consistency and safety across the legal cannabis market. Understanding these innovations helps clinicians and…
Indiana Governor Signals Potential Shift on Marijuana Legalization
Indiana medical cannabis program challenges are gaining attention as the governor signals openness to legalization discussions. Clinicians should prepare for new clinical oversight and patient safety protocols. This evolving policy landscape impacts…
Newsom Takes Credit for Legalizing Marijuana in California and Discusses Complexities
This article reviews cannabis legalization public health evidence in light of Governor Newsom's recent policy changes. It discusses how these changes may influence clinical research pathways and patient care. The focus is on balancing regulatory progress…
